BackMolecule Holdings Overview

Molecule Holdings Current Cash

Track Molecule Holdings's current cash ($140K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$141927.00
↑ 93.74% YoYΔ $68672.00 vs prior year quarter

Peer trimmed avg / median

Loading

Molecule Holdings Current Cash History

Loading

Molecule Holdings vs. peers: Current Cash Comparison

Loading

Molecule Holdings Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Molecule Holdings (EVRRF) FAQ

As of the most recent data (July 2023), EVRRF shows a current cash of $140K. That compares with $73K in the prior-year period — up 93.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EVRRF's current cash is now $140K (was $73K) — a 93.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Molecule Holdings is outperforming or lagging.

Tracking EVRRF's current cash over time shows whether Molecule Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $140K That compares with $73K in the prior-year period — up 93.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Molecule Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $140K) with ownership activity and broader fundamentals.